PFEB:FRA
Pfizer CAD Hedged CDR
€7.65
arrow_downward
-0.65%(-0.050) 1D
Oct 14, 8:01:16 AM GMT+2 · EUR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFEB...
Open
€7.65
High
€7.65
Low
€7.65
Mkt. cap
4.66B
Avg. vol.
0.00
Volume
0.00
52-wk high
€8.25
52-wk low
€5.80
No. of employees
10K
Open
€7.65
High
€7.65
Low
€7.65
Mkt. cap
4.66B
Avg. vol.
0.00
Volume
0.00
52-wk high
€8.25
52-wk low
€5.80
No. of employees
10K
News stories
From web sources and news partners
MarketBeat
·
25 minutes ago
X-Energy (NASDAQ:XE) Reaches New 12-Month Low - Time to Sell?
FXStreet
·
46 minutes ago
Dow Jones futures advance as US Treasury yields, oil prices ease
Investor's Business Daily
·
6 hours ago
Tech Futures Rise: Meta, AMD Lead 5 Buys; ASML, CPI Inflation Due
Seeking Alpha
·
2 hours ago
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
About Pfizer CAD Hedged CDR
CEONgit Liong Wong | Ngit Liong Wong
Employees9.9K
Founded1989
Headquarters-
SectorDistillery
Websiteventure.com.sg
Previous reportsAll values in SGD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in SGD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 636.33M | 636.33M | 677.34M | 677.34M |
Cost of goods sold | 457.43M | 457.43M | 489.02M | 489.02M |
Cost of revenue | 457.43M | 457.43M | 489.02M | 489.02M |
Research and development expenses | 5.34M | 5.34M | 6.55M | 6.55M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 81.62M | 81.62M | 82.66M | 82.66M |
Operating expense | 116.86M | 116.86M | 120.35M | 120.35M |
Total operating expenses | 574.29M | 574.29M | 609.37M | 609.37M |
Operating income | 62.03M | 62.03M | 67.97M | 67.97M |
Other non operating income | 465.00K | 465.00K | 346.00K | 346.00K |
EBT including unusual items | 71.57M | 71.57M | 74.92M | 74.92M |
EBT excluding unusual items | 71.57M | 71.57M | 74.92M | 74.92M |
Income tax expense | 14.41M | 14.41M | 15.13M | 15.13M |
Effective tax rate | 20.13% | 20.13% | 20.19% | 20.19% |
Other operating expenses | 21.35M | 21.35M | 22.28M | 22.28M |
Net income | 56.99M | 56.99M | 59.65M | 59.65M |
Net profit margin | 8.96% | 8.96% | 8.81% | 8.81% |
Earnings per share | - | - | - | - |
Interest and investment income | 9.08M | 9.08M | 6.60M | 6.60M |
Interest expense | -220.00K | -220.00K | -172.50K | -172.50K |
Net interest expenses | 8.86M | 8.86M | 6.43M | 6.43M |
Depreciation and amortization charges | 8.56M | 8.56M | 8.86M | 8.86M |
EBITDA | 67.43M | 67.43M | 73.80M | 73.80M |
Gain or loss from assets sale | -15.00K | -15.00K | - | - |